Nadia Emi Aikawa

Scopus Publications

Prolonged skin involvement distinguishes adolescent from childhood-onset IgA vasculitis: a large multicenter study with 687 patients
Luisa Fernanda Caro Forero, Paula Santana Marra, Ricardo Nobrega Machado, Clara Ribeiro Doria, Sebastian Durán Cordoba, Lia Vineyard Steuer, Matheus Santos França, Sylvia Costa Lima Farhat, Izabel Mantovani Buscatti, Gleice Clemente Souza Russo, Maria Teresa Terreri, Mayra Siqueira Dantas, Luciana M. Carvalho, Francisco H. R. Gomes, Natalia Maronese, Adriana R. Fonseca, Marta C. F. Rodrigues, Andreia Watanabe, Lucia M. A. Campos, Adriana Maluf Elias, Verena Andrade Balbi, Nadia Emi Aikawa, Vivianne S. L. Viana, Lara R. C. Melo, Claudia A. A. Strabelli, Magda Maria Sales Carneiro-Sampaio, Katia Tomie Kozu, Clovis Artur Silva
Advances in Rheumatology, 2026
Immunoglobulin A vasculitis (IgAV), also known as Henoch- Schönlein purpura (HSP), is the most common systemic vasculitis in childhood. Potential differences in demographic characteristics, clinical presentation, laboratory findings, and treatments approaches across age groups, remain poorly explored. To the best of our knowledge, no multicenter study in Latin America has systematically addressed these features. We aimed to assess demographic, clinical and laboratory features, and treatments in children versus adolescents with (IgAV)/ (HSP) in a large multicenter study. A multicenter study involving four tertiary centers evaluated 687 children and adolescents (≤ 18 years-old) with IgAV/HSP (EULAR/PRINTO/PRES classification criteria) at first 3 months after diagnosis. The charts were retrospectively assessed for demographic data, initial clinical manifestations, laboratory tests and treatments. Data were compared between children (< 10 years-old) and adolescents (≥ 10 years-old), according to WHO definition. IgAV/HSP was diagnosed in 599/687(87%) children [5.33(0.88–9.91) years-old] and 88/687(13%) adolescents [11.33(10-17.5) years-old]. The median duration of purpura/petechiae was significantly lower in children compared to adolescents [14(1-120) vs. 15(2–90) days, p = 0.04]. The frequency of persistent purpura/petechiae (≥ 6 weeks of duration) was significantly reduced in the former group (7.2% vs. 19.5%, p = 0.002), likewise the frequency of gastrointestinal bleeding (17% vs. 34.1%, p = 0.01) and proteinuria (49.7% vs. 84%, p = 0.002). In contrast, the frequencies of arthritis/arthralgia (82.7% vs. 73%, p = 0.03) and orchitis(16.6% vs. 4.8%, p = 0.04) were significantly higher in children. Further analysis of laboratory tests showed that the median value of serum IgA was significantly lower in children than in adolescents [179.1(40-1002.0) vs. 279.0(104.0-488.0) mg/dL, p = 0.01], whereas thrombocytosis was higher (40.1% vs. 23%, p = 0.007). Logistic regression demonstrated that persistent purpura/petechiae after IgAV/HSP diagnosis (OR = 18.337; 95%CI 1.245-270.137; p = 0.034) was the only independently associated variable with dependent variable (adolescent). In this large multicenter cohort, IgAV/HSP onset occurred rarely at adolescence, with a more prominent cutaneous involvement. Prolonged purpura/petechiae after IgAV/HSP diagnosis was associated with adolescent-onset IgAV/HSP, reinforcing the need for vigilant monitoring in this subgroup.
Lower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren’s disease patients: evidence from a randomized double-blinded placebo-controlled trial
Sandra Gofinet Pasoto, Talita de Oliveira Ribeiro, Nádia Emi Aikawa, Ana Cristina Medeiros-Ribeiro, Bruno da Silva Borges, André Silva Franco, Cássia Gisele Terrassani Silveira, Henrique Carriço da Silva, Eloisa Bonfa, Clovis Artur Almeida da Silva
Seminars in Arthritis and Rheumatism, 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study
Nadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, Leonard V K Kupa, Luciana P C Seguro, Ana P Luppino-Assad, Eduardo F Borba, Carla G S Saad, Emily F N Yuki, Danieli C O Andrade, Andrea Y Shimabuco, Karina R Bonfiglioli, Diogo S Domiciano, Julio C B Moares, Samuel K Shinjo, Percival D Sampaio-Barros, Henrique A M Giardini, João C S de Oliveira, Isabele P B Antonelli, Renata L P Mello, Thais B Gorayeb, Lucas G N Farias, Andrea A Negrini, Fernanda G G Chaer, Ana C S L Praxedes, Marta H Lopes, Clovis A Silva, Eloisa Bonfa
Lancet Rheumatology, 2026
Effect of hydroxychloroquine dose reduction (2–3 mg/kg/day) on lipoprotein levels in stable lupus nephritis: A 12-month randomized controlled longitudinal study
Dilson Marreiros Nunes Filho, Nadia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, Luciana Parente Costa Seguro, Emily Figueiredo Neves Yuki, Michelle Remião Ugolini Lopes, Clovis Artur Silva, Eloisa Silva Dutra de Oliveira Bonfá, Eduardo Ferreira Borba Neto
Lupus, 2026
Objective To evaluate whether hydroxychloroquine (HCQ) dose reduction (2–3 mg/kg/day) sustain lipoprotein levels achieved with higher doses of 2016-American Academy of Ophthalmology (2016-AAO) in stable lupus nephritis (LN) patients. Methods Forty-seven consecutive stable LN patients using HCQ 2016-AAO recommended dose for ≥6 months were enrolled and assigned to one of two groups: Reduced HCQ group (n = 21):LN patients who, upon inclusion, reduced 2016-AAO dose (2–3 mg/kg/day); and Maintenance HCQ group ( n = 26):LN patients who continued on the standard 2016-AAO recommended HCQ dose (4.0–5.5 mg/kg actual body weight, maximum 400 mg/day) throughout 12-month study period. Blood HCQ levels, lipid profile and SLE parameters (including SLEDAI-2K) were assessed at baseline, 3 and 12-month. Results Baseline demographics, comorbidities and disease parameters were similar among groups ( p > .05). Initial blood levels of Reduced HCQ group were 1219.4 (1041.7–1926.6)ng/mL and a progressive significant decrease were identified after 3 and 12 months [651.2 (538.4–832.6)vs.468.8 (228.4–925.6)ng/mL, p < .001]. Maintenance HCQ group had no changes in HCQ levels during the study [1179.7 (905.5–1607.3)vs.1026.2 (710.5-1345.8)vs.907.9 (663.9-1304.2)ng/mL, p = .158]. No changes were observed on the longitudinal total cholesterol levels of Reduced HCQ [166 (113–198)vs.153 (85–192)vs.150 (90–231)mg/dL, p = .964] and Maintenance HCQ [155 (114–244)vs.154 (122–210)vs.155 (112–213)mg/dL, p = .395]. LDL cholesterol levels of Reduced HCQ [91 (52–163)vs.83 (41–136vs.87 (47–165)mg/dL, p = .917] and Maintenance HCQ [79 (36–114)vs.76.5 (33–111)vs.75.5 (63–131)mg/dL, p = .412] remained similar. Other lipoprotein levels remained stable during 1 year of study. Conclusion This is the first study to show that reducing HCQ to 2-3 mg/kg/day preserves lipid stability over 12 months in stable lupus nephritis patients.
Painful subcutaneous edema is associated with early age at disease onset in Immunoglobulin A vasculitis patients: A multicenter study
Lia V. Steuer, Clara R. Doria, Matheus S. França, Paula S. Marra, Sebastian D. Cordoba, Luisa F.C. Forero, Ricardo N. Machado, Sylvia C.L. Farhat, Gleice Clemente, Vitória Curi, Claudio A. Len, Luciana M. Carvalho, Francisco H.R. Gomes, Virginia P.L. Ferriani, Rozana G. de Almeida, Flavio R. Sztajnbok, Lucia M.A. Campos, Adriana M. Elias, Verena A. Balbi, Nadia E. Aikawa, Beatriz O.L. Carneiro, Magda Carneiro-Sampaio, Katia T. Kozu, Clovis A.A. Silva
Clinics, 2026
OBJECTIVE: To evaluate the risk factors associated with the presence of Painful Subcutaneous Edema (PSE) in children and adolescents with Immunoglobulin A Vasculitis (IgAV). METHODS: A multicenter study evaluated 686 patients (≤ 18 years-old) at first 3-months after diagnosis. IgAV patients with PSE were compared to those without PSE. RESULTS: ) (43.8 % vs. 35.1 %, p = 0.04). Although associated with higher inflammatory markers, PSE was not linked to more severe outcomes. Logistic regression demonstrated that age at diagnosis was inversely associated with PSE (OR = 0.986; 95 % CI 0.981‒0.992; p < 0.001). CONCLUSION: PSE occurred in approximately one-third-of IgAV patients at disease onset and was diagnosed predominantly at an early age, with a more inflammatory presentation at onset. However, in spite of the higher levels of inflammatory markers, PSE was not linked to more severe outcomes.
A real-life study of juvenile idiopathic arthritis from two Brazilian referral centers for pediatric rheumatology
Ana María Loroño Terrazas, Raúl Gutiérrez Suárez, Reinan Tavares Campos, Claudio Arnaldo Len, Nadia Emi Aikawa, Jade Dib Fernandez, Mayra Lisyer Dantas, Clóvis Artur Silva, Gleice Clemente, Maria Teresa Terreri
Advances in Rheumatology, 2025
Background Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood, but its outcomes are still difficult to determine. We aimed to obtain outcome measurements of disease activity, functional capacity, disease damage, and therapeutic response, at one-year follow-up study on a real-life basis. Methods An observational JIA cohort from two referral centers for pediatric rheumatology in Brazil Pediatric Rheumatology Centers was carried out over a period of one year. Clinimetric validated outcome measurements were applied over four visits. Multivariable logistic regression was performed to evaluate baseline variables associated with the following outcomes after one year of follow-up: disease activity, Minimal Disease Activity (MDA), disease flare, remission on medication and remission off medication. Results A total of 127 patients were included in the study. Eighty-three (65.4%) were females, and median time to diagnosis was 6.0 months. JADAS71 and CHAQ improved during follow-up (mean Vbaseline 7.05 ± 9.3 vs. V52 3.52 ± 8.4; 0 ± 0.5 vs. 0.14 ± 0.4, p < 0.001, respectively) as well as JIA-ACR 30, 50, 70 and 90 (Vbaseline 79.8% vs. V52 88.8%; 71.4% vs. 84.1%; 59.7% vs. 77.6%; 49.6% vs. 69.2%, p < 0.05, respectively). Inactive disease was present in 33% of patients at baseline and in 67.9% at V52 (p < 0.001). Remission on medication, remission off medication and MDA were present in 46%, 11%, and 80.6% of patients at V52, respectively. Extra-articular and articular damage were not common at baseline (0.3 ± 0.7 and 1.1 ± 3.4 respectively) and did not decrease significantly during the period of the study. The presence of active joints 46/101 (45.5%) at baseline reduced the chance of the patient achieving remission off medication at the last visit by 84% (OR = 0.16; CI 95% from 0.03 to 0.91, p = 0.039). Conclusion This study showed improvement in clinimetric outcome measurements and therapeutic responses in an inception cohort of JIA patients. The presence of active joints at baseline is related to not achieving remission at last visit. Long-term prospective and multicenter studies are needed to better assess the outcome of JIA and the differences among JIA subtypes.
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with rheumatoid arthritis: a 12-month observational study
Fanny Reyes-Neira, Barbara Bayeh, Karina Rossi Bonfiglioli, Nadia Emi Aikawa, Ana Paula Luppino Assad, Renata Miossi, Fernando Henrique Carlos de Souza, Carlos Emilio Insfran, Henrique Ayres Mayrink Giardini, Emily Figueiredo Neves Yuki, Eloisa Bonfa, Carla Gonçalves Schahin Saad, Julio Cesar Bertacini de Moraes, Ana Cristina de Medeiros-Ribeiro, Andrea Yukie Shimabuco
Advances in Rheumatology, 2025
TNF-inhibitors like adalimumab (ADA) have been vital for managing rheumatoid arthritis (RA) for over two decades. With the emergence of biosimilars, real-life evidence is crucial to confirm their sustained efficacy after switching from originator drugs. This study aims to provide comprehensive evaluation of the clinical outcomes of transitioning from adalimumab reference product (ADA-RP) to the biosimilar adalimumab–AACF (ADA-AACF) in patients with RA over a 12-month period in a real-world analysis. This observational study included RA patients who had been on ADA-RP for at least three months before switching to ADA-AACF. Disease activity parameters, including DAS28-CRP, CDAI, SDAI, and CRP-levels, were assessed at baseline (T0) and compared at 6 (T6) and 12 months (T12) following the switch. Sixteen patients were included, with a mean duration of ADA-RP use of 69.9 months. DAS28-CRP remained stable when comparing T0 to T6 [2.36 (1.92–2.84) vs. 1.83 (1.72–3.16), p = 0.988] and T12 [2.36 (1.92–2.84) vs. 2.54 (2.09–2.86), p = 0.874], with similar results for SDAI and CDAI (p > 0.05). The frequency of low disease activity was consistent during the follow-up: 81.3% at T0; 68.8% at T6 (p = 0.617) and 81.3% at T12 (p = 0.480) for DAS28-CRP < 3.2. The same pattern was observed for CDAI ≤ 10 and SDAI ≤ 11 (p > 0.05). CRP-levels and prednisone doses did not show significant variation (p > 0.05) across time points. The biosimilar retention rate was 87.5%, with two patients discontinuing biosimilar before the 12-month mark. This real-world study demonstrates the feasibility and sustained efficacy of transitioning from ADA-RP to ADA-AACF in RA patients, reinforcing its role in long-term disease management. These findings in an ethnically diverse population contribute to the growing global evidence on biosimilar adoption, supporting their integration into routine clinical practice and expanding treatment accessibility.
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases Launching a Randomized Phase 4 Study
Leonard V.K. Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E. Aikawa, Sandra G. Pasoto, Eduardo F. Borba, Ana Paula L. Assad, Carla G.S. Saad, Emily F.N. Yuki, Luciana P.C. Seguro, Danieli Andrade, Samuel K. Shinjo, Percival D. Sampaio-Barros, Andrea Y. Shimabuco, Júlio Cesar B. Moraes, Vanderson S. Sampaio, Henrique A. M. Giardini, Clovis A.A. Silva, Eloisa Bonfá
Journal of Clinical Rheumatology, 2025
Background Patients with autoimmune rheumatic diseases (ARDs) are at an increased risk for herpes zoster (HZ). Vaccination is recommended for this population. Objective The aim of this study was to evaluate the safety of vaccination with the recombinant zoster vaccine (Shingrix) in ARD patients, humoral immunogenicity (HI), cellular immunogenicity (CI), and the incidence of HZ. Methods This randomized, double-blind, placebo-controlled phase 4 study involves 1180 ARD patients and a control group (CG) of 393 balanced healthy individuals, aged ≥50 years. ARD patients will be randomly assigned in a blinded manner (1:1 ratio) to 2 groups: vaccine or placebo (on days 0 and 42), administered intramuscularly. Outcomes will be assessed at baseline, 6 weeks, and 12 weeks after vaccination, including disease activity (using specific disease activity scores), HI, and CI. Adverse events will be assessed using a standardized questionnaire after each vaccine dose. Incident HZ cases will be monitored throughout the study. One year following the second dose, the persistence of HI and CI will be evaluated in both ARD patients and CG. HI and CI will be assessed using serum concentrations of anti-gE antibodies and the frequencies of gE-specific CD4+ T cells, respectively. Comparisons of anti-gE titers between ARD patients and CG at different time points will be analyzed using 2-way repeated-measures analysis of variance. Multiple regression analysis will be conducted, with a positive immune response as the dependent variable, and variables with p < 0.2 from univariate analysis as independent variables. Conclusions This large trial addresses a critical gap by examining disease safety, efficacy, adverse effects, and immunogenicity, considering the impact of diverse therapies following recombinant zoster vaccine administration in ARD patients.
Autoantibody clusters in childhood-onset systemic lupus erythematosus: Insights from a multicenter study with 912 patients
Vitor C Trindade, Eloisa Bonfá, Ana P Sakamoto, Maria T Terreri, Nádia E Aikawa, Fernanda J Fiorot, Ana C Pitta, Verena A Balbi, Carlos N Rabelo, Marco F Silva, Aline G Islabão, Glaucia V Novak, Katia T Kozu, Izabel M Buscatti, Lucia M Campos, Adriana ME Sallum, Ana P Assad, Claudia S Magalhães, Roberto Marini, Adriana R Fonseca, Flavio R Sztajnbok, Maria C Santos, Blanca E Bica, Evaldo G Sena, Ana J Moraes, Teresa C Robazzi, Paulo F Spelling, Iloite M Scheibel, Andre S Cavalcanti, Erica N Matos, Luciano J Guimarães, Flavia P Santos, Luciana M Carvalho, Magda Carneiro-Sampaio, Alexandre A Ferraro, Clovis A Silva
Lupus, 2025
Objective: To identify clusters of autoantibodies in a large cSLE population and to verify possible associations between different autoantibody clusters and the following variables: demographic data, cumulative clinical and laboratory manifestations, disease activity, cumulative damage and mortality. Methods: A cross-sectional study was performed in 27 Pediatric Rheumatology University centers, including 912 cSLE patients. The frequencies of seven selected autoantibodies (anti-dsDNA, anti-Ro/SSA, anti-La/SSB, anti-Sm, anti-RNP, aCL IgM and/or IgG and LA) were used for cluster analysis using the K-means method. Results: Four distinctive antibody clusters were identified. Cluster 1 ( n = 322; 35.31%) was characterized by anti-dsDNA (61.18%), low frequency of antiphospholipid antibodies (<10%), and lower frequency of cutaneous, articular manifestation ( p < 0.05) and hypocomplementemia ( p < 0.001) compared to the other groups. Cluster 2 ( n = 158; 17.32%) comprised anti-dsDNA (93.04%), aCL (87.34%) and LA (39.87%) and higher frequencies of thrombocytopenia ( p = 0.006) and antiphospholipid syndrome ( p < 0.001) than the other clusters. Cluster 3 ( n = 177; 19.41%) was characterized by anti-dsDNA (81.36%), anti-Sm (100%) and anti-RNP (44.63%) antibodies, as well as a higher frequency of proteinuria compared to cluster 4 (58.15% vs 56.13% vs 64.00% vs 49.80%, p = 0.031). Cluster 4 ( n = 255; 27.96%) consisted of all 7 autoantibodies, with predominance of anti-dsDNA (72.55%), anti-Ro/SSA (89.8%) and anti-La/SSB (45.88%), with no specific clinical pattern, except by higher pulmonary damage ( p = 0.017). Conclusions:Our study suggests that, within the context of cSLE, the coexistence of anti-dsDNA with antiphospholipid autoantibodies is linked to an elevated incidence of antiphospholipid syndrome. This association does not coincide with a proportionate increase in the occurrence of nephritis. Conversely, the cluster of anti-dsDNA with anti-Ro/SSA and anti-La/SSB antibodies was associated with pulmonary damage, requiring close surveillance.
Metabolomics in juvenile idiopathic arthritis: A distinct profile in patients under methotrexate
Renato B. Tomioka, Gabriela R.V. Ferreira, Nadia E. Aikawa, Gustavo A.R. Maciel, José M. Soares Junior, Edmund C. Baracat, Eloisa Bonfá, Ismael Dale Cotrim Guerreiro da Silva, Clovis Almeida da Silva
Clinics, 2025
• We identified a distinctive pattern of serum metabolic signatures in juvenile idiopathic arthritis patients under methotrexate therapy. • Methotrexate use is associated with a more efficient mitochondrial function. • A decreased mitochondrial metabolism was observed in polyarticular and systemic JIA subtypes, with a decrease of several acylcarnitines’ concentrations. The objective of the present study was to evaluate biochemical quantitative metabolites in peripheral blood serum samples of Juvenile Idiopathic Arthritis (JIA) patients and healthy controls. A cross-sectional study included 33 post-pubertal JIA (21 without and 12 with Methotrexate (MTX) women and 28 age-matched healthy controls. Metabolomic analyses based on targeted electrospray ionization tandem mass spectrometry were used to identify possible biochemical pathway modifications in serum from JIA patients. The mean current age ( p = 0.065) was similar in JIA patients and healthy controls. Current MTX use in all subtypes of JIA patients was associated with an increase in concentrations of free carnitine [21.74 (12.7‒35.2) vs. 27.49 (14.5‒41.3) µM/L, p = 0.02], suggesting an enhanced mitochondrial metabolism and intestinal absorptive function. In contrast, a decreased mitochondrial metabolism was observed in polyarticular and systemic JIA subtypes, with a decrease of several acylcarnitines’ concentrations ( p < 0.05). In conclusion, the present study identified a distinctive pattern of serum metabolic signatures in JIA patients under MTX therapy. Our findings indicate that MTX use is associated with a more efficient mitochondrial function.
Quantitative PCR for parasitemia monitoring and preemptive therapy in patients with Chagas disease and autoimmune rheumatic disorders undergoing biologic treatment: a case series
Noemia Barbosa Carvalho, Vera Lucia Teixeira de Freitas, Nadia Emi Aikawa, Lucas Teixeira Vieira, Rita Cristina Bezerra, Adriana Coraccini Tonácio de Proença, Karina Bonfiglioli, Érika Yoshie Shimoda Nakanishi, Hermes Ryoiti Higashino, Maria Aparecida Shikanai-Yasuda
Revista Da Sociedade Brasileira De Medicina Tropical, 2025
The influence of environmental factors related to Juvenile Dermatomyositis (JDM), its course and refractoriness to treatment
Clarissa C.M. Valões, Tamima M. Arabi, Alfésio L.F. Braga, Lúcia M.A. Campos, Nádia E. Aikawa, Kátia T. Kozu, Clovis A. Silva, Sylvia C.L. Farhat, Adriana M. Elias
Advances in Rheumatology, 2024
Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren's disease: randomised placebo-controlled double-blind clinical study
Juliana D'Agostino Gennari, Giordano B.H. Deveza, Carolina T. Ribeiro, Antonio C. Seguro, Nádia E. Aikawa, Maria Heloisa M. Shimizu, Elaine Pires Leon, Lissiane K.N. Guedes, Léonard V.K. Kupa, Clovis A.A. Silva, Eloisa Bonfa, Sandra Gofinet Pasoto
Clinical and Experimental Rheumatology, 2024
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering
Clarissa Q. Pimentel, Ana Cristina Medeiros‐Ribeiro, Andrea Y. Shimabuco, Percival D. Sampaio‐Barros, Júlio César B. Moraes, Claudia G. Schainberg, Celio Roberto Gonçalves, Elaine P. Leon, Léonard De Vinci K. Kupa, Sandra G. Pasoto, Nádia E. Aikawa, Clovis A. Silva, Eloisa Bonfa, Carla G. S. Saad
Arthritis and Rheumatology, 2024
Updates in the care and management of children and adolescents with systemic lupus erythematosus
Clovis A. Silva, Nadia E. Aikawa, Eloisa Bonfa
Current Opinion in Rheumatology, 2024
Assessment of hydroxychloroquine blood levels in Sjögren’s disease patients: drug adherence and clinical associations
Sandra Gofinet Pasoto, Lorena Elizabeth Betancourt Villamarín, Léonard de Vinci Kanda Kupa, Giordano Bruno Henriques Deveza, Carolina Torres Ribeiro, Nádia Emi Aikawa, Elaine Pires Leon, Victor Adriano de Oliveira Martins, Clovis Artur Silva, Eloisa Bonfa
Rheumatology International, 2024
Autoinflammatory diseases: a Latin American multicenter study according to age and sex
Daniela Gerent Petry Piotto, Katia Kozu, Nádia Emi Aikawa, Pedro Lopes Carneiro, María Martha Katsicas, Sheila Knupp Feitosa de Oliveira, Taciana de Albuquerque Pedrosa Fernandes, Claudia Saad Magalhães, Ana Luiza Garcia Cunha, Blanca Elena Rios Gomes Bica, Carlos Nobre Rabelo Júnior, Cristina Battagliotti, Erica Naomi Naka Matos, Flavia Patrícia Sena Teixeira Santos, Flavio Roberto Sztajnbok, Liliana Bezrodnik, Marcia Bandeira, Marta Cristine Felix Rodrigues, Pablo García Munittis, Simone Appenzeller, Teresa Cristina Martins Robazzi, Gleice Clemente, Clovis Artur Silva, Maria Teresa Terreri
Revista Paulista De Pediatria, 2024
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus
Nadia Emi Aikawa, Eduardo Ferreira Borba, Verena Andrade Balbi, Adriana Maluf Elias Sallum, Izabel Mantovani Buscatti, Lucia Maria Arruda Campos, Kátia Tomie Kozu, Cristiana Couto Garcia, Artur Silva Vidal Capão, Adriana Coracini Tonacio de Proença, Elaine Pires Leon, Alberto José da Silva Duarte, Marta Heloisa Lopes, Clovis Artur Silva, Eloisa Bonfá
Advances in Rheumatology, 2023
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition
Clovis Artur Silva, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Sandra Gofinet Pasoto, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Joaquim Ivo Vasques Dantas Landim, Victor Hugo Ferreira e Léda, Luisa Sacchi de Camargo Correia, Artur Fonseca Sartori, Carolina Campagnoli Machado Freire Martins, Carolina Torres Ribeiro, Filipe Waridel, Victor Adriano de Oliveira Martins, Samuel Katsuyuki Shinjo, Danieli Castro Oliveira Andrade, Percival Degrava Sampaio Barros, Eduardo Ferreira Borba Neto, Nadia Emi Aikawa, Eloisa Bonfa
Advances in Rheumatology, 2023
Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjögren syndrome
Sandra Gofinet Pasoto, Eduardo Ferreira Borba, Francisco Fellipe Claudino Formiga, Tatiana do Nascimento Pedrosa, Nadia Emi Aikawa, Marilda Agudo Mendonça Teixeira de Siqueira, Artur Silva Vidal Capão, Adriana Coracini Tonacio de Proença, Ricardo Fuller, Emily Figueiredo Neves Yuki, Elaine Pires Leon, Victor Adriano de Oliveira Martins, Marta Heloisa Lopes, Alberto José da Silva Duarte, Clovis Artur Almeida da Silva, Eloisa Bonfa
Clinical Rheumatology, 2023
Body Composition and Phase Angle: How to Improve Nutritional Evaluation in Juvenile Dermatomyositis Patients
Camila Pugliese, Artur Figueiredo Delgado, Katia Tomie Kozu, Lucia Maria de Arruda Campos, Nadia Emi Aikawa, Clovis Artur Silva, Adriana Maluf Elias
Nutrients, 2023
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset
Gabriela A. Munhoz, Nadia E. Aikawa, Clovis A. Silva, Sandra G. Pasoto, Tatiana N. Pedrosa, Luciana P. C. Seguro, Eloisa Bonfa, Eduardo F. Borba
Journal of Clinical Rheumatology, 2023
Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus
Ana P. Sakamoto, Clovis A. Silva, Aline G. Islabão, Glaucia V. Novak, Beatriz Molinari, Paulo K. Nogueira, Rosa M. R. Pereira, Claudia Saad-Magalhães, Gleice Clemente, Daniela P. Piotto, Nadia E. Aikawa, Ana C. Pitta, Vitor C. Trindade, Simone Appenzeller, Luciana M. Carvalho, Carlos N. Rabelo-Junior, Adriana R. Fonseca, Flavio R. Sztajnbok, Maria C. Santos, Blanca E. Bica, Evaldo G. Sena, Ana J. Moraes, Melissa M. Fraga, Teresa C. Robazzi, Paulo F. Spelling, Iloite M. Scheibel, Andre S. Cavalcanti, Erica N. Matos, Luciano J. Guimarães, Flavia P. Santos, Licia M. H. Mota, Eloisa Bonfá, Maria T. Terreri, and
Pediatric Nephrology, 2023
Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients
Ana P Sakamoto, Clovis A Silva, Ana C Pita, Vitor C Trindade, Aline G Islabao, Fernanda J Fiorot, Sandra RM Lopes, Rosa MR Pereira, Claudia Saad-Magalhaes, Gleice CS Russo, Claudio A Len, Rogerio do Prado, Lucia MA Campos, Nadia E Aikawa, Simone Appenzeller, Virginia PL Ferriani, Marco F Silva, Marta Felix, Adriana R Fonseca, Ana PL Assad, Flavio R Sztajnbok, Maria C Santos, Blanca E Bica, Evaldo G Sena, Ana J Moraes, Melissa M Fraga, Teresa C Robazzi, Paulo F Spelling, Iloite M Scheibel, Andre S Cavalcanti, Erica N Matos, Luciano J Guimaraes, Flavia P Santos, Licia MH Mota, Eloisa Bonfa, Maria T Terreri
Lupus, 2023
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases
Bruno Gualano, Sofia M. Sieczkowska, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana J. Pinto, Bruna C. Mazzolani, Fabiana I. Smaira, Nadia E. Aikawa, Leonard V.K. Kupa, Sandra G. Pasoto, Ana C. Medeiros-Ribeiro, Carla G.S. Saad, Emily F.N. Yuk, Clovis A. Silva, Paul Swinton, Pedro C. Hallal, Hamilton Roschel, Eloisa Bonfa
Journal of Physical Activity and Health, 2023
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
Carla G.S. Saad, Matheus S.R. Silva, Perceval D. Sampaio-Barros, Julio C.B. Moraes, Cláudia G. Schainberg, Celio R. Gonçalves, Andrea Y. Shimabuco, Nadia E. Aikawa, Emily F.N. Yuki, Sandra G. Pasoto, Leonard V.K. Kupa, Renato K. Aoyama, Carlo S.R. Araujo, Clóvis A. Silva, Ana C. Medeiros-Ribeiro, Eloisa Bonfa
Joint Bone Spine, 2023
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Rosa M.R. Pereira, Marilia A. Dagostin, Valeria F. Caparbo, Lucas P. Sales, Sandra G. Pasoto, Clovis A. Silva, Emily F.N. Yuki, Carla G.S. Saad, Ana C. Medeiros-Ribeiro, Leonard V.K. Kupa, Solange R.G. Fusco, Victor A.O. Martins, Carolina C.M.F. Martins, Carmen Valente Barbas, Samuel K. Shinjo, Nadia E. Aikawa, Eloisa Bonfa
Clinics, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination
Fabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana J. Pinto, Sofia M. Sieczkowska, Nadia E. Aikawa, Sandra G. Pasoto, Ana C. Medeiros-Ribeiro, Carla G.S. Saad, Emily F.N. Yuk, Clovis A. Silva, Paul Swinton, Leonard de Vinci Kanda Kupa, Pedro C. Hallal, Hamilton Roschel, Bruno Gualano, Eloisa Bonfa
Journal of Physical Activity and Health, 2023
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine
Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, Carla G S Saad, Sandra G Pasoto, Emily F N Yuki, Solange R G Fusco, Samuel K Shinjo, Danieli C O Andrade, Percival D Sampaio-Barros, Rosa M R Pereira, Anna C S Chasin, Andrea Y Shimabuco, Ana P Luppino-Assad, Elaine P Leon, Marta H Lopes, Leila Antonangelo, Ana C Medeiros-Ribeiro, Eloisa Bonfa
Rheumatology United Kingdom, 2023
Food consumption based on processing level (according to Nova system) during the COVID-19 pandemic among adolescents with immunocompromised conditions: a case-control study
Gabriel P. Esteves, Bruna Caruso Mazzolani, Fabiana Infante Smaira, Heloísa C. Santo André, Amanda Yuri Iraha, Camilla Astley, Isabela Gouveia Marques, Milla Cordeiro Amarante, Nathalia Saffioti Rezende, Sofia Mendes Sieczkowska, Tathiane Christine Franco, Luana Cristina do Amaral Miranda, Lívia Lindoso, Alberto Carame Helito, Jane Oba, Ligia Bruni Queiroz, Rosa Maria R. Pereira, Lucia Maria A. Campos, Nadia E. Aikawa, Hamilton Roschel, Clovis A. Silva, Bruno Gualano
Frontiers in Nutrition, 2023
Emotional, hyperactivity and inattention problems in adolescents with immunocompromising chronic diseases during the COVID-19 pandemic
Reinan T. Campos, Livia Lindoso, Renan A. de Sousa, Alberto C. Helito, Bianca P. Ihara, Claudia A.A. Strabelli, Levi M.V. Paradelas, Beatriz O.L. Carneiro, Maria Paula R. Cardoso, Jean Paulo V. de Souza, Marianna R. de M. Freire, Camilla Astley, Moisés F. Laurentino, Izabel M. Buscatti, Katia Kozu, Nadia E. Aikawa, Adriana M.E. Sallum, Juliana C.O. Ferreira, Juliana R. Simon, Vivianne S.L. Viana, Ligia B. Queiroz, Bruno Gualano, Hamilton Roschel, Rosa Maria R. Pereira, Ricardo K. Toma, Andréia Watanabe, Patricia M. Grangeiro, Caio B. Casella, Sylvia C. Farhat, Guilherme V. Polanczyk, Lucia Maria A. Campos, Clovis A. Silva
Clinics, 2023
Primary dental care treatment in primary Sjögren’s syndrome: a possible role in improving salivary flow rate
Victor A.O. Martins, Tamires F. Floriano, Elaine P. Leon, Lorena E.B. Villamarín, Giordano B.H. Deveza, Nádia E. Aikawa, Clovis A.A. Silva, Léonard V.K. Kupa, Maria Paula S.M. Peres, Paulo H. Braz-Silva, Eloisa Bonfá, Sandra G. Pasoto
Clinical and Experimental Rheumatology, 2022
Does [18F]F-FDG-PET/MRI add metabolic information to magnetic resonance image in childhood-onset Takayasu’s arteritis patients? A multicenter case series
Gleice Clemente, Alexandre W. de Souza, Hilton Leão Filho, Fernando M. A. Coelho, Carlos Buchpiguel, Marcos Lima, Camila Carneiro, Rosa M. R. Pereira, Nadia Aikawa, Clovis A. Silva, Lucia M. A. Campos, Gabriel Alves, Camilla Astley, Bruno Gualano, Maria Teresa Terreri
Advances in Rheumatology, 2022
Spotlight on latent tuberculosis infection screening for juvenile idiopathic arthritis in two countries, comparing high and low risk patients
Daniela Piotto, Aline Nicacio, Agna Neto, Ana Filipa Mourão, Filipa Oliveira-Ramos, Raquel Campanilho-Marques, Margarida Guedes, Marta Cabral, Maria José Santos, João Eurico Fonseca, Helena Canhão, Nádia Emi Aikawa, Sheila K. F. Oliveira, Virginia P. L. Ferriani, Gecilmara C. S. Pileggi, Claudia S. Magalhães, Clovis Artur Silva, Maria Teresa Terreri
Advances in Rheumatology, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
Clovis A. Silva, Ana C. Medeiros-Ribeiro, Leonard V. K. Kupa, Emily F. N. Yuki, Sandra G. Pasoto, Carla G. S. Saad, Solange R. G. Fusco, Rosa M. R. Pereira, Samuel K. Shinjo, Ari S. R. Halpern, Eduardo F. Borba, Fernando H. C. Souza, Lissiane K. N. Guedes, Renata Miossi, Karina R. Bonfiglioli, Diogo S. Domiciano, Andrea Y. Shimabuco, Danieli C. O. Andrade, Luciana P. C. Seguro, Ricardo Fuller, Percival D. Sampaio-Barros, Ana P. L. Assad, Julio C. B. Moraes, Claudia Goldenstein-Schainberg, Henrique A. M. Giardini, Henrique C. Silva, Victor A. O. Martins, Lorena E. B. Villamarin, Renata S. Novellino, Lucas P. Sales, Carlo S. R. Araújo, Matheus S. R. Silva, Dilson M. N. Filho, Marta H. Lopes, Alberto J. S. Duarte, Esper G. Kallas, Nadia E. Aikawa, Eloisa Bonfa
Nature Communications, 2022
Heart function in juvenile idiopathic arthritis patients: A biventricular two-dimensional speckle-tracking echocardiography study
Alessandro C Lianza, Gabriela N Leal, Nádia E Aikawa, Katia T Kozu, Maria De Fátima R Diniz, Karen S S Sawamura, Carolina R B Menezes, Camila Lino Martins, Lucia M Campos, Adriana M Elias, Clovis A Silva
Modern Rheumatology, 2022
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients
Bruno Gualano, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana Jéssica Pinto, Bruna Caruso Mazzolani, Fabiana Infante Smaira, Sofia Mendes Sieczkowska, Nádia Emi Aikawa, Sandra Pasoto, Ana Cristina Medeiros‐Ribeiro, Carla Saad, Emily Yuk, Clovis Silva, Paul Swinton, Pedro Curi Hallal, Hamilton Roschel, Eloisa Bonfa
Scandinavian Journal of Medicine and Science in Sports, 2022
COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions
Bianca P. Ihara, Lívia M. Lindoso, Debora N. D. Setoue, Nicolas Y. Tanigava, Alberto C. Helito, Juliana R. Simon, Vivianne S. L. Viana, Claudia A. A. Strabelli, Camilla A. A. Pedroso, Sofia M. Sieczkowska, Rosa M. R. Pereira, Nádia E. Aikawa, Katia T. Kozu, Adriana M. Elias, Izabel M. Buscatti, Bruno Gualano, Ligia B. Queiroz, Caio B. Casella, Guilherme V. Polanczyk, Clovis A. A. Silva, Lucia M. M. A. Campos
Clinical Rheumatology, 2022
Discontinuing methotrexate to enhance vaccine response
Ana C. Medeiros-Ribeiro, Nadia E. Aikawa
Nature Reviews Rheumatology, 2022
Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring
Renata Soares Novellino, Marc Yves Chalom, Paschoalina Romano, Persio de Almeida Rezende Ebner, Julia Celestino Seraphim, Ana Carolina Silva do Amaral, Nilo Jose Coelho Duarte, Tatiana Do Nascimento Pedrosa, Emily Figueiredo Neves Yuki, Nadia Emi Aikawa, Sandra Gofinet Pasoto, Clovis Artur Almeida da Silva, Valdemir Melechco Carvalho, Eloisa Bonfá, Léonard de Vinci Kanda Kupa
Bioanalysis, 2022
Systemic autoimmune myopathies: A prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, Alexandre M dos Santos, Renata Miossi, Rafael G Misse, Ana C Medeiros-Ribeiro, Carla G S Saad, Emily F N Yuki, Sandra G Pasoto, Léonard V K Kupa, Carina Ceneviva, Júlia C Seraphim, Tatiana N Pedrosa, Margarete B G Vendramini, Clóvis A Silva, Nádia E Aikawa, Eloisa Bonfá
Rheumatology United Kingdom, 2022
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus
Nicolas Y Tanigava, Ana P Sakamoto, André S Franco, Gabriela GM Balbi, Lucas P Sales, Nadia E Aikawa, Maria T Terreri, Rosa MR Pereira
Lupus, 2022
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome
F. Signorelli, G. Balbi, N. Aikawa, Clóvis A. Silva, Léonard V K Kupa, A. Medeiros-Ribeiro, Emily Fn Yuki, S. Pasoto, Carla Gs Saad, E. Borba, L. Seguro, T. Pedrosa, V. D. A. Oliveira, Ana Luisa Cerqueira de Sant'Ana Costa, C. T. Ribeiro, Roseli Eliana Beseggio Santos, D. Andrade, E. Bonfá
Lupus, 2022
Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity
Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, Ana Cristina Medeiros Ribeiro, Emily Neves Figueiredo Yuki, Carla Gonçalves Schahin Saad, Clovis Artur Almeida da Silva, Léonard de Vinci Kanda Kupa, Lorena Elizabeth Betancourt Villamarín, Victor Adriano de Oliveira Martins, Carolina Campagnoli Machado Freire Martins, Giordano Bruno Henriques Deveza, Elaine Pires Leon, Cleonice Bueno, Tatiana Nascimento Pedrosa, Roseli Eliana Beseggio Santos, Renata Soares, Nádia Emi Aikawa, Eloisa Bonfa
Clinical Rheumatology, 2022
SARS-CoV-2 vaccine in patients with systemic sclerosis: Impact of disease subtype and therapy
Percival Degrava Sampaio-Barros, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino-Assad, Renata Miossi, Henrique Carriço da Silva, Emily F V N Yuki, Sandra G Pasoto, Carla G S Saad, Clóvis A Silva, Léonard V K Kupa, Giordano B H Deveza, Tatiana N Pedrosa, Nádia E Aikawa, Eloisa Bonfá
Rheumatology United Kingdom, 2022
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
Lucas C Netto, Karim Y Ibrahim, Camila M Picone, Ana Paula P S Alves, Eliane V Aniceto, Mariana R Santiago, Patrícia S S Parmejani, Nadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, Emily F N Yuki, Carla G S Saad, Tatiana Pedrosa, Amanda N Lara, Carina Ceneviva, Eloisa Bonfa, Esper G Kallas, Vivian I Avelino-Silva
Lancet HIV, 2022
2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus
Carlos E. Insfrán, Nadia E. Aikawa, Sandra G. Pasoto, Dilson M. N. Filho, Francisco F. C. Formiga, Ana C. Pitta, Eduardo F. Borba, Carolina T. Ribeiro, Clovis A. Silva, Eloisa Bonfa
Clinical Rheumatology, 2022
Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
Nádia Emi Aikawa, Verena Andrade Balbi, Eduardo Ferreira Borba, Adriana Coracini Tonacio, Adriana Maluf Elias Sallum, Lucia Maria Arruda Campos, Kátia Tomie Kozu, Margarete Borges Vendramini, Nicole Fontoura, Adriana de Souza Azevedo, Waleska Dias Schwarcz, Ana Marli Christovam Sartori, Leila Antonangelo, Clovis Artur Silva, Eloisa Bonfá
Vaccine X, 2022
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.
Sofia Mendes Sieczkowska, Camilla Astley, Isabela Gouveia Marques, Amanda Yuri Iraha, Tathiane Christine Franco, Bianca Pires Ihara, Sofia Simão Martins Lavorato, Livia Lindoso, Debora Narumi Demitrol Setoue, Nicolas Yamada Tanigava, Lucia Maria Arruda Campos, Rosa Maria Rodrigues Pereira, Nadia Emi Aikawa, Hamilton Roschel, Ligia Bruni Queiroz, Guilherme V. Polanczyk, Clovis Artur Silva, Bruno Gualano
Lupus, 2022
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus
Emily F. N. Yuki, Eduardo F. Borba, Sandra G. Pasoto, Luciana P. Seguro, Michelle Lopes, Carla G. S. Saad, Ana Cristina Medeiros‐Ribeiro, Clovis A. Silva, Danieli C. O. Andrade, Leonard de Vinci K. Kupa, Lorena Betancourt, Isabela Bertoglio, Juliana Valim, Camilla Hoff, Francisco F. C. Formiga, Tatiana Pedrosa, Esper G. Kallas, Nadia E. Aikawa, Eloisa Bonfa
Arthritis Care and Research, 2022
Mental Health Impact in Latin American Pediatric Rheumatologists during the COVID-19 Pandemic
Kátia T. Kozu, Caio B. Casella, Claudia A.A. Strabelli, Nadia E. Aikawa, Lucia M.A. Campos, Adriana M. Elias, Eurípedes C. Miguel, Guilherme V. Polanczyk, Clovis A. Silva
Journal of Clinical Rheumatology, 2022
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
Bruno Gualano, Italo R. Lemes, Rafael P. Silva, Ana J. Pinto, Bruna C. Mazzolani, Fabiana I. Smaira, Sofia M. Sieczkowska, Nadia E. Aikawa, Sandra G. Pasoto, Ana C. Medeiros-Ribeiro, Carla G.S. Saad, Emily F.N. Yuki, Clovis A. Silva, Paul Swinton, Pedro C. Hallal, Hamilton Roschel, Eloisa Bonfa
Brain Behavior and Immunity, 2022
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
Bruno Gualano, Carla G. S. Saad, Sofia M. Sieczkowska, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana J. Pinto, Bruna C. Mazzolani, Fabiana I. Smaira, Saulo Gil, Gersiel Oliveira-Junior, Nadia E. Aikawa, Ana C. Medeiros-Ribeiro, Clovis A. Silva, Emily F. N. Yuki, Sandra G. Pasoto, Rosa Maria R. Pereira, Samuel K. Shinjo, Danieli C. O. Andrade, Percival D. Sampaio-Barros, Hamilton Roschel, Eloisa Bonfa
Journal of Applied Physiology, 2022
Is positron emission tomography/magnetic resonance imaging a reliable tool for detecting vascular activity in treated childhood-onset Takayasu's arteritis? A multicentre study
Gleice Clemente, Rosa M R Pereira, Nadia Aikawa, Clovis A Silva, Lucia M A Campos, Gabriel Alves, Carlos Buchpiguel, Marcos Lima, Camila Carneiro, Hilton L Filho, Fernando Morbeck, Guilherme Neto, Vicente O Filho, Alexandre W D Souza, Maria Teresa Terreri
Rheumatology United Kingdom, 2022
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, Ana C Medeiros-Ribeiro, Emily F N Yuki, Carla G S Saad, Tatiana Pedrosa, Ricardo Fuller, Samuel K Shinjo, Percival D Sampaio-Barros, Danieli C O Andrade, Rosa M R Pereira, Luciana P C Seguro, Juliana M L Valim, Filipe Waridel, Ana Marli C Sartori, Alberto J S Duarte, Leila Antonangelo, Ester C Sabino, Paulo Rossi Menezes, Esper G Kallas, Clovis A Silva, Eloisa Bonfa
Lancet Rheumatology, 2022
Intermittent abdominal pain in IgA vasculitis
Izabel Mantovani Buscatti, Juliana Russo Simon, Vivianne Saraiva Leitao Viana, Tamima Mohamad Abou Arabi, Vitor Cavalcanti Trindade, Ana Carolina Cortez Maia, Lara Regina Cavalcante Melo, Bianca Pires Ihara, Nadia Emi Aikawa, Clovis Artur Silva
Revista Paulista De Pediatria, 2022
Monitoring and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis: Brazilian Evidence-based Practice Guidelines
LM Neves, LM Haefeli, LM Hopker, F Ejzenbaum, H Moraes do Nascimento, N Aikawa, MO Hilario, CS Magalhães, MT Terreri, F Sztajnbok, CAA Silva, JD Rossetto
Ocular Immunology and Inflammation, 2022
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis
Verena Andrade Balbi, Clovis Artur Silva, Tatiana Nascimento Pedrosa, Rosa Maria Rodrigues Pereira, Lucia Maria de Arruda Campos, Elaine Pires Leon, Nilo Duarte, Valdemir Melechco Carvalho, Sandra Gofinet Pasoto, Debora Cordeiro do Rosário, Leticia Kolachinski Brandao, Hermine I Brunner, Eloisa Bonfá, Nadia Emi Aikawa
Lupus, 2022
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana Pedrosa, Leonard de Vinci Kanda Kupa, Gioanna Zou, Rosa M R Pereira, Clóvis Artur Silva, Nádia Emi Aikawa, Eloisa Bonfa
Annals of the Rheumatic Diseases, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Henrique Carriço da Silva, Carla G S Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Carlo Scognamiglio Renner Araujo, Tatiane Lie Nakai, Clóvis Artur Silva, Tatiana Pedrosa, Léonard de Vinci Kanda Kupa, Matheus Santos Rodrigues Silva, Guilherme Guimarães Moreira Balbi, Esper Georges Kallas, Nádia Emi Aikawa, Eloisa Bonfa
Annals of the Rheumatic Diseases, 2022
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Nádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Carla Goncalves Schahin Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Percival Degrava Sampaio-Barros, Danieli Castro Oliveira Andrade, Ari Stiel Radu Halpern, Ricardo Fuller, Fernando Henrique Carlos Souza, Lissiane Karine Noronha Guedes, Ana Paula Luppino Assad, Julio Cesar Bertacini de Moraes, Michelle Remiao Ugolini Lopes, Victor Adriano de Oliveira Martins, Lorena Betancourt, Carolina Torres Ribeiro, Lucas Peixoto Sales, Isabela Maria Bertoglio, Virginia Lucia Nazario Bonoldi, Renata Lys Pinheiro Mello, Gustavo Guimaraes Moreira Balbi, Ana Marli Christovam Sartori, Leila Antonangelo, Clóvis Artur Silva, Eloisa Bonfa
Annals of the Rheumatic Diseases, 2022
Poor physical activity levels and cardiorespiratory fitness among patients with childhood-onset takayasu arteritis in remission: a cross‐sectional, multicenter study
Camilla Astley, Saulo Gil, Gleice Clemente, Maria Teresa Terreri, Clovis Artur Silva, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Ana Lúcia de Sá Pinto, Rosa Maria R. Pereira, Hamilton Roschel, Bruno Gualano
Pediatric Rheumatology, 2021
Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a mixed methods study
Camilla Astley, Sofia Mendes Sieczkowska, Isabela Gouveia Marques, Bianca Pires Ihara, Livia Lindoso, Sofia Simão Martins Lavorato, Lucia Maria Arruda Campos, Rosa Maria Rodrigues Pereira, Adriana Maluf Elias, Nadia Emi Aikawa, Katia Kozu, Amanda Yuri Iraha, Tathiane Christine Franco, Hamilton Roschel, Ligia Bruni Queiroz, Guilherme Vanoni Polanczyk, Clovis Artur Silva, Bruno Gualano
Pediatric Rheumatology, 2021
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients
Ana C Pitta, Clovis A Silva, Carlos E Insfrán, Sandra G Pasoto, Vitor C Trindade, Glaucia V Novak, Ana P Sakamoto, Maria T Terreri, Rosa MR Pereira, Claudia S Magalhães, Adriana R Fonseca, Aline G Islabão, Ana PL Assad, Izabel M Buscatti, Adriana M Elias, Daniela P Piotto, Virginia P Ferriani, Luciana M Carvalho, Carlos N Rabelo Junior, Roberto Marini, Flavio R Sztajnbok, Silvana B Sacchetti, Blanca E Bica, Ana J Moraes, Teresa C Robazzi, Simone Lotufo, Andre S Cavalcanti, Erica N Naka, Magda Carneiro-Sampaio, Eloisa Bonfá, Nadia E Aikawa, and
Lupus, 2021
Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients
Isabela Maria Bertoglio, Juliana Miranda de Lucena Valim, Danielle Daffre, Nádia Emi Aikawa, Clovis Artur Silva, Eloisa Bonfá, Michelle Remião Ugolini‐Lopes
Acr Open Rheumatology, 2021
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases
Adriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba, Nadia Emi Aikawa, Sandra Gofinet Pasoto, Júlio Cesar Rente Ferreira Filho, Marília Mantovani Sampaio Barros, Elaine Pires Leon, Suzete Cleusa Ferreira Spina Lombardi, Alfredo Mendrone Junior, Adriana de Souza Azevedo, Waleska Dias Schwarcz, Ricardo Fuller, Emily Figueiredo Neves Yuki, Michelle Remião Ugolini Lopes, Rosa Maria Rodrigues Pereira, Percival Degrava Sampaio Barros, Danieli Castro Oliveira de Andrade, Ana Cristina de Medeiros-Ribeiro, Julio Cesar Bertacini de Moraes, Samuel Katsuyuki Shinjo, Renata Miossi, Alberto José da Silva Duarte, Marta Heloisa Lopes, Esper Georges Kallás, Clovis Artur Almeida da Silva, Eloisa Bonfá
Plos Neglected Tropical Diseases, 2021
Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicity
Francisco Fellipe Claudino Formiga, Clovis Artur Silva, Tatiana do Nascimento Pedrosa, Nadia Emi Aikawa, Sandra Gofinet Pasoto, Cristiana Couto Garcia, Artur Silva Vidal Capão, Victor Adriano de Oliveira Martins, Adriana Coracini Tonacio de Proença, Ricardo Fuller, Emily Figueiredo Neves Yuki, Margarete Borges Galhardo Vendramini, Debora Cordeiro do Rosário, Leticia Maria Kolachinski Raposo Brandão, Ana Marli Christovam Sartori, Leila Antonangelo, Eloisa Bonfá, Eduardo Ferreira Borba
Lupus, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana C. Medeiros-Ribeiro, Nadia E. Aikawa, Carla G. S. Saad, Emily F. N. Yuki, Tatiana Pedrosa, Solange R. G. Fusco, Priscila T. Rojo, Rosa M. R. Pereira, Samuel K. Shinjo, Danieli C. O. Andrade, Percival D. Sampaio-Barros, Carolina T. Ribeiro, Giordano B. H. Deveza, Victor A. O. Martins, Clovis A. Silva, Marta H. Lopes, Alberto J. S. Duarte, Leila Antonangelo, Ester C. Sabino, Esper G. Kallas, Sandra G. Pasoto, Eloisa Bonfa
Nature Medicine, 2021
Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment: A Narrative Review of Literature for Clinical Practice
Emily Figueiredo Neves Yuki, Clovis A. Silva, Nadia E. Aikawa, Ricardo Romiti, Carlos Otto Heise, Eloisa Bonfa, Sandra Gofinet Pasoto
Journal of Clinical Rheumatology, 2021
Adrenal steroidogenesis and ovarian reserve in adult childhood-onset systemic lupus erytematosus patients
Daniela M. R. Lourenço, Daniel B. Araújo, Nadia E. Aikawa, Lucas Y. S. Yamakami, Eduardo F. Borba, Gustavo A. R. Maciel, Jose M. Soares-Junior, Edmund C. Baracat, Rosa M. R. Pereira, Eloisa Bonfa, Clovis A. Silva
Clinical Rheumatology, 2021
Home-Based Exercise Training in Childhood-Onset Takayasu Arteritis: A Multicenter, Randomized, Controlled Trial
Camilla Astley, Gleice Clemente, Maria Teresa Terreri, Camila G. Carneiro, Marcos S. Lima, Carlos Alberto Buchpiguel, Hilton Leão Filho, Ana Lúcia de Sá Pinto, Clovis Artur Silva, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Saulo Gil, Rosa Maria Rodrigues Pereira, Hamilton Roschel, Bruno Gualano
Frontiers in Immunology, 2021
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial
Caio B. Zanetti, Tatiana Pedrosa, Léonard de V. K. Kupa, Nadia E. Aikawa, Eduardo F. Borba, Margarete B. G. Vendramini, Clovis A. Silva, Sandra G. Pasoto, Eloisa Bonfa
Clinical Rheumatology, 2021
One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels
Emily Figueiredo Neves Yuki, Renata Soares, Léonard de Vinci Kanda Kupa, Carlos Otto Heise, Nadia Emi Aikawa, Marcelo Arnone, Ricardo Romiti, Tatiana do Nascimento Pedrosa, Clovis Artur Almeida da Silva, Eloisa Bonfa, Sandra Gofinet Pasoto
Lupus, 2021
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients
Tatiana Pedrosa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, Nádia Emi Aikawa, Eduardo Ferreira Borba, Nilo JC Duarte, Elaine Pires Leon, Clovis Artur Silva, Eloisa Bonfá
Lupus, 2021
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital
Bianca P Ihara, Claudia AA Strabelli, Juliana R Simon, Vivianne SL Viana, Adriana ME Sallum, Katia T Kozu, Nádia E Aikawa, Gabriela N Leal, Maria FB Pereira, Heloisa H Marques, Clovis A Silva, Lúcia M Campos
Lupus, 2021
The heart of pediatric patients with covid-19: New insights from a systematic echocardiographic study in a tertiary hospital in Brazil
Maria de Fátima Rodrigues Diniz, Maira Freire Cardoso, Karen Saori Shiraishi Sawamura, Carolina Rocha Brito Menezes, Alessandro Cavalcanti Lianza, Maria Fernanda Badue Pereira, Nadia Litvinov, Juliana Ferreira Ferranti, Silvana Forsait, Andreia Watanabe, Sylvia Costa Lima Farhat, Nadia Emi Aikawa, Lucia Maria Arruda Campos, Artur Figueiredo Delgado, Magda Carneiro-Sampaio, Werther Brunow de Carvalho, Clovis Artur Silva, Gabriela Nunes Leal
Arquivos Brasileiros De Cardiologia, 2021
Lupus nephritis-related issues during COVID-19 pandemic quarantine
Tatiana Pedrosa, Léonard de Vinci Kanda Kupa, Nádia Emi Aikawa, Sandra Gofinet Pasoto, Eloisa Bonfá, Clovis Artur Silva
Lupus, 2020
Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker
Fany Solange Usuba, Ana Cristina de Medeiros-Ribeiro, Priscila Novaes, Nadia Emi Aikawa, Karina Bonfiglioli, Ruth Miyuki Santo, Eloisa Bonfá, Milton Ruiz Alves
Scientific Reports, 2020
Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up
Fany Solange Usuba, Carla Gonçalves Schahin Saad, Nadia Emi Aikawa, Priscila Novaes, Julio Cesar Bertacini Moraes, Ruth Miyuki Santo, Jozelio Freire Carvalho, Eloisa Bonfá, Milton Ruiz Alves
Scientific Reports, 2020
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
Ingrid Herta Rotstein Grein, Natalia Balera Ferreira Pinto, Noortje Groot, Camila Bertini Martins, Aline Lobo, Nadia Emi Aikawa, Cassia Barbosa, Maria Teresa Terreri, Aline Coelho Moreira da Fraga, Sheila Knupp Feitosa de Oliveira, Flavio Sztajnbok, Luciana B. Paim Marques, Aline Garcia Islabão, Simone Appenzeller, Blanca Bica, Juliana de Oliveira Sato, Claudia Saad Magalhães, Virgínia Ferriani, Hella Pasmans, Rutger Schepp, Fiona van der Klis, Sytze de Roock, Nico Wulffraat, Gecilmara Salviato Pileggi
Pediatric Rheumatology, 2020
Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients
Aline G. Islabão, Licia M.H. Mota, Maria Custodia M. Ribeiro, Tamima M. Arabi, Georgiana N. Cividatti, Ligia B. Queiroz, Danieli C. Andrade, Ana P. Sakamoto, Vitor C. Trindade, Glaucia V. Novak, Beatriz C. Molinari, Lucia M. Campos, Nádia E. Aikawa, Rosa M.R. Pereira, Maria T. Terreri, Claudia S. Magalhães, Roberto Marini, Hugo R. Gomes, Marco F. Silva, Sheila K. Oliveira, Flavio R. Sztajnbok, Silvana B. Sacchetti, Blanca E. Bica, Evaldo G. Sena, Ana P. Moraes, Maria C. Santos, Teresa C. Robazzi, Paulo F. Spelling, Iloite M. Scheibel, Andre S. Cavalcanti, Erica N. Naka, Luciano J. Guimarães, Flavia P. Santos, Magda C. Sampaio, Eloisa Bonfá, Clovis A. Silva
Autoimmunity Reviews, 2020
Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis
Tatiana N Pedrosa, Sandra G Pasoto, Nadia E Aikawa, Emily FN Yuki, Eduardo F Borba, Julio CR Ferreira Filho, Pedro C Carricondo, Caio B Zanetti, Paola G Conde, Nilo JC Duarte, Nicole Fontoura, Paschoalina Romano, Valdemir M Carvalho, Clovis A Silva, Eloisa Bonfa
Lupus, 2020
Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching
Juliana Barbosa Brunelli, Clovis Almeida Silva, Sandra Gofinet Pasoto, Carla Gonçalves Schahin Saa, Katia Tomie Kozu, Claudia Goldenstein-Schainberg, Elaine Pires Leon, Margarete B. G. Vendramini, Nicole Fontoura, Eloisa Bonfa, Nádia Emi Aikawa
Clinical Rheumatology, 2020
Lower genital tract infections in young female juvenile idiopathic arthritis patients
Gabriela R. V. Ferreira, Renato B. Tomioka, Ligia B. Queiroz, Katia Kozu, Nadia E. Aikawa, Adriana M. E. Sallum, Paulo Serafini, Maricy Tacla, Edmund C. Baracat, Rosa M. R. Pereira, Eloisa Bonfá, Clovis A. Silva
Advances in Rheumatology, 2019
Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity
Brazilian Childhood-onset Systemic Lupus Erythematosus Group, Fernanda J. Fiorot, Aline G. Islabão, Rosa M. Pereira, Maria T. Terreri, Claudia Saad-Magalhães, Glaucia V. Novak, Beatriz C. Molinari, Ana P. Sakamoto, Nadia E. Aikawa, Lucia M. Campos, Octavio A. Peracchi, Simone Appenzeller, Virgínia P. Ferriani, Marco F. Silva, Adriana R. Fonseca, Flávio R. Sztajnbok, Luciana B. Paim, Melissa M. Fraga, Eunice M. Okuda, Blanca E. Bica, Evaldo G. Sena, Ana J. Moraes, Ana M. Rolim, Paulo F. Spelling, Iloite M. Scheibel, André S. Cavalcanti, Erica N. Matos, Teresa C. Robazzi, Luciano J. Guimarães, Flávia P. Santos, Valeria C. Ramos, Magda Carneiro-Sampaio, Eloisa Bonfá, Clovis A. Silva
Clinical Rheumatology, 2019
Risk factors for bone loss in juvenile-onset systemic lupus erythematosus: a prospective study
L F A de Sousa, J A Paupitz, N E Aikawa, L Takayama, V F Caparbo, R M R Pereira
Lupus, 2019
Ovarian reserve in young juvenile idiopathic arthritis patients
Gabriela R V Ferreira, Renato B Tomioka, Nadia E Aikawa, Elaine P Leon, Gustavo A R Maciel, Paulo C Serafini, Edmund C Baracat, Claudia Goldenstein-Schainberg, Rosa M R Pereira, Eloisa Bonfá, Clovis A Silva
Modern Rheumatology, 2019
Sexual function in female juvenile idiopathic arthritis patients
Ana Claudia Pitta, Gabriela Ribeiro Viola Ferreira, Renato Bussadori Tomioka, Daniela Mencaroni Rodrigues Lourenço, Katia Kozu, Nadia Emi Aikawa, Adriana Maluf Elias Sallum, Lucia Maria Arruda Campos, Carmita Helena Najjar Abdo, Rosa Maria Rodrigues Pereira, Edmund Chada Baracat, Eloisa Bonfá, Clovis Artur Silva
Advances in Rheumatology London England, 2019
Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study
Mônica Verdier, Pedro Anuardo, Natali Weniger Spelling Gormezano, Ricardo Romiti, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Rosa Maria Rodrigues Pereira, Maria Teresa Terreri, Claudia Saad Magalhães, Juliana C. O. A. Ferreira, Marco Felipe Castro Silva, Mariana Ferriani, Ana Paula Sakamoto, Virginia Paes Leme Ferriani, Maraísa Centeville, Juliana Sato, Maria Carolina Santos, Eloisa Bonfá, Clovis Artur Silva
Advances in Rheumatology London England, 2019
Increased soluble cytoplasmic Bcl-2 protein serum levels and expression and decreased fas expression in lymphocytes and monocytes in juvenile dermatomyositis
Bernadete L. Liphaus, Adriana E.M. Sallum, Nadia E. Aikawa, Maria Helena B. Kiss, Solange Carrasco, Patricia Palmeira, Laila Lima, Clovis A. Silva, Claudia Goldenstein-Schainberg, Magda Carneiro-Sampaio
Journal of Rheumatology, 2018
Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients
Renato B. Tomioka, Gabriela R. V. Ferreira, Nadia E. Aikawa, Gustavo A. R. Maciel, Paulo C. Serafini, Adriana M. Sallum, Lucia M. A. Campos, Claudia Goldestein-Schainberg, Eloisa Bonfá, Clovis A. Silva
Clinical Rheumatology, 2018
Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis
Percival D Sampaio-Barros, Danieli C O Andrade, Luciana C P Seguro, Sandra G Pasoto, Vilma S T Viana, Ana C M Ribeiro, Nadia E Aikawa, Maria do Carmo S Timenetsky, Alexander R Precioso, Clóvis A Silva, Eloisa Bonfa
Rheumatology United Kingdom, 2018
Juvenile dermatomyositis: is periodontal disease associated with dyslipidemia?
Kátia T. Kozu, Clovis A. Silva, Nadia E. Aikawa, Rosa M. R. Pereira, Adriana M. Sallum, Cynthia Savioli, Eduardo Borba, Lucia M. Campos
Advances in Rheumatology London England, 2018
Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study
G V Novak, B C Molinari, J C Ferreira, A P Sakamoto, MT Terreri, R M R Pereira, C Saad-Magalhães, N E Aikawa, L M Campos, C A Len, S Appenzeller, V P Ferriani, M F Silva, S K Oliveira, A G Islabão, F R Sztajnbok, L B Paim, C M Barbosa, M C Santos, B E Bica, E G Sena, A J Moraes, A M Rolim, P F Spelling, I M Scheibel, A S Cavalcanti, E N Matos, T C Robazzi, L J Guimarães, F P Santos, C T Silva, E Bonfá, C A Silva
Lupus, 2018
Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE
Gladys Cherres Xavier Esteves, Natali Weniger Spelling Gormezano, Oriany L Pereira, David Kern, Clovis Almeida Silva, Rosa Maria Rodrigues Pereira, Katia Tomie Kozu, Eloisa Bonfá, Nadia Emi Aikawa
Modern Rheumatology, 2018
Correction to: Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center (Clinical Rheumatology, (2018), 37, 5, (1319-1324), 10.1007/s10067-017-3972-3)
Izabel M. Buscatti, Beatriz B. Casella, Nadia E. Aikawa, Andrea Watanabe, Sylvia C. L. Farhat, Lucia M. A. Campos, Clovis Artur Silva
Clinical Rheumatology, 2018
Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center
Izabel M. Buscatti, Beatriz B. Casella, Nadia E. Aikawa, Andrea Watanabe, Sylvia C. L. Farhat, Lucia M. A. Campos, Clovis Artur Silva
Clinical Rheumatology, 2018
High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting
Juliana Barbosa Brunelli, Ana Renata Schmidt, Adriana Maluf Elias Sallum, Claudia Goldenstein-Schainberg, Eloisa Bonfá, Clovis A Silva, Nádia Emi Aikawa
Modern Rheumatology, 2018
A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT
G. L. Lima, J. A. Paupitz, N. E. Aikawa, J. C. Alvarenga, R. M. Rodrigues Pereira
Osteoporosis International, 2018
Autoimmune hepatitis in 847 childhoodonset systemic lupus erythematosus population: A multicentric cohort study
Verena A. Balbi, Bárbara Montenegro, Ana C. Pitta, Ana R. Schmidt, Sylvia C. Farhat, Laila P. Coelho, Juliana C. O. Ferreira, Rosa M. R. Pereira, Maria T. Terreri, Claudia Saad-Magalhães, Nadia E. Aikawa, Ana P. Sakamoto, Kátia Kozu, Lucia M. Campos, Adriana M. Sallum, Virginia P. Ferriani, Daniela P. Piotto, Eloisa Bonfá, Clovis A. Silva
Advances in Rheumatology, 2018
Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome
Brazilian Childhood-onset Systemic Lupus Erythematosus Group, Gabriela Blay, Joaquim C. Rodrigues, Juliana C. O. Ferreira, Gabriela N. Leal, Natali W. Gormezano, Glaucia V. Novak, Rosa M. R. Pereira, Maria T. Terreri, Claudia S. Magalhães, Beatriz C. Molinari, Ana P. Sakamoto, Nadia E. Aikawa, Lucia M. A. Campos, Taciana A. P. Fernandes, Gleice Clemente, Octavio A. B. Peracchi, Vanessa Bugni, Roberto Marini, Silvana B. Sacchetti, Luciana M. Carvalho, Melissa M. Fraga, Tânia C. M. Castro, Valéria C. Ramos, Eloisa Bonfá, Clovis A. Silva
Advances in Rheumatology, 2018
Disseminated histoplamosis in adolescent mimicking granulomatosis with polyangiitis
Marlon van Weelden, Gabriela R. Viola, Katia T. Kozu, Nadia E. Aikawa, Claudia M. Ivo, Clovis A. Silva
Revista Brasileira De Reumatologia, 2017
Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti‐TNF therapy in a tuberculosis high‐risk country
Juliana Barbosa Brunelli, Karina Rossi Bonfiglioli, Clovis A. Silva, Katia Tomie Kozu, Claudia Goldenstein‐Schainberg, Eloisa Bonfa, Nadia Emi Aikawa
Revista Brasileira De Reumatologia, 2017
Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups
S R M Lopes, N W S Gormezano, R C Gomes, N E Aikawa, R M R Pereira, M T Terreri, C S Magalhães, J C Ferreira, E M Okuda, A P Sakamoto, A M E Sallum, S Appenzeller, V P L Ferriani, C M Barbosa, S Lotufo, A A Jesus, L E C Andrade, L M A Campos, E Bonfá, C A Silva, Brazilian Childhood-onset Systemic Lupus Erythematosus Group
Lupus, 2017
Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: Differences between pediatric and adult patients
N W S Gormezano, D Kern, O L Pereira, G C X Esteves, A M E Sallum, N E Aikawa, R M R Pereira, C A Silva, E Bonfá
Lupus, 2017
Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations
Pedro Anuardo, Monica Verdier, Natali W. S. Gormezano, Gabriela R. V. Ferreira, Gabriela N. Leal, Alessandro Lianza, Juliana C. O. A. Ferreira, Rosa M. R. Pereira, Nadia E. Aikawa, Maria Teresa Terreri, Claudia S. Magalhães, Simone Appenzeller, Maria Carolina dos Santos, Silvana B. Sachetti, Claudio A. Len, Gecilmara S. Pilleggi, Simone Lotufo, Eloisa Bonfá, Clovis A. Silva
Pediatric Cardiology, 2017
Substance use and sexual function in juvenile idiopathic arthritis
Marlon van Weelden, Benito Lourenço, Gabriela R. Viola, Nadia E. Aikawa, Lígia B. Queiroz, Clovis A. Silva
Revista Brasileira De Reumatologia, 2016
Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study
Gabriella E. Lube, Mariana Paes Leme Ferriani, Lucia Maria Arruda Campos, Maria Teresa Terreri, Eloisa Bonfá, Claudia Saad Magalhães, Nadia Emi Aikawa, Daniela Petry Piotto, Octavio Augusto Bedin Peracchi, Maria Carolina dos Santos, Simone Appenzeller, Virginia Paes Leme Ferriani, Rosa Maria Rodrigues Pereira, Clovis Artur Silva
Pediatric Blood and Cancer, 2016
CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature—a rare case with a novel mutation
Miria Paula V. Cavalcante, Juliana B. Brunelli, Clarissa C. Miranda, Glaucia V. Novak, Louise Malle, Nadia E. Aikawa, Adriana A. Jesus, Clovis Artur Silva
European Journal of Pediatrics, 2016
Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy
Clovis Artur Silva, Nadia Emi Aikawa, Rosa Maria Rodrigues Pereira, Lucia Maria Arruda Campos
Expert Review of Clinical Immunology, 2016
Pancreatitis subtypes survey in 852 childhood-onset systemic lupus erythematosus patients
Victor L.S. Marques, Natali W.S. Gormezano, Eloisa Bonfá, Nadia E. Aikawa, Maria T. Terreri, Rosa M. Pereira, Claudia S. Magalhães, Andressa Guariento, Simone Appenzeller, Virgínia P. Ferriani, Cássia M. Barbosa, Valéria C. Ramos, Simone Lotufo, Clovis A. Silva
Journal of Pediatric Gastroenterology and Nutrition, 2016
Hepatitis C virus antibodies in high risk juvenile onset systemic lupus erythematosus
Nádia E. Aikawa, Ana P. Nascimento, André L.S. Hayata, Eloisa Bonfá, Cláudia Goldenstein-Schainberg
Revista Brasileira De Reumatologia, 2016
Intracerebral hemorrhage with a favorable outcome in a patient with childhood primary angiitis of the central nervous system
Marco Felipe Silva, Ana Raquel Feitosa, José A. Paz, Nádia Emi Aikawa, Clovis A. Silva
Revista Brasileira De Reumatologia, 2016
Vitamin D Supplementation in Adolescents and Young Adults with Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial
Glauce L. Lima, Juliane Paupitz, Nadia E. Aikawa, Liliam Takayama, Eloisa Bonfa, Rosa M. R. Pereira
Arthritis Care and Research, 2016
Systemic and localized infection by Candida species in patients with rheumatic diseases receiving anti-TNF therapy
Nadia E. Aikawa, Daniela T.A. Rosa, Gilda M.B. Del Negro, Julio C.B. Moraes, Ana C.M. Ribeiro, Carla Gonçalves Saad, Clovis A. Silva, Eloisa Bonfá
Revista Brasileira De Reumatologia, 2016
Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients
Natali W. S. Gormezano, Clovis A. Silva, Nadia E. Aikawa, Diego L. Barros, Mariana A. da Silva, Carini I. Otsuzi, Katia Kozu, Luciana Parente Seguro, Rosa M. R. Pereira, Eloisa Bonfá
Clinical Rheumatology, 2016
Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus
Hermine I. Brunner, Clovis A. Silva, Andreas Reiff, Gloria C. Higgins, Lisa Imundo, Calvin B. Williams, Carol A. Wallace, Nadia E. Aikawa, Shannen Nelson, Marisa S. Klein‐Gitelman, Susan R. Rose
Arthritis and Rheumatology, 2015
Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy
Nadia E. Aikawa, Ivan L.A. França, Ana C. Ribeiro, Adriana M.E. Sallum, Eloisa Bonfa, Clovis A. Silva
Vaccine, 2015
Childhood-onset bullous systemic lupus erythematosus
D M R Lourenço, R Cunha Gomes, N E Aikawa, L M A Campos, R Romiti, C A Silva
Lupus, 2014
Ovarian reserve in adult patients with childhood-onset lupus: A possible deleterious effect of methotrexate?
DB de Araujo, LYS Yamakami, NE Aikawa, E Bonfá, VST Viana, SG Pasoto, RMR Pereira, PC Serafin, EF Borba, CA Silva
Scandinavian Journal of Rheumatology, 2014
Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the "CAPS registry"
Horacio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, Simone Gregory, Ernesto de Meis, Carlos Ewerton Maia Rodrigues, Nádia Emi Aikawa, Jozélio Freire de Carvalho, Janusz Springer, Maciej Niedzwiecki, Gerard Espinosa
Autoimmunity Reviews, 2014
Autoimmune primary ovarian insufficiency
C.A. Silva, L.Y.S. Yamakami, N.E. Aikawa, D.B. Araujo, J.F. Carvalho, E. Bonfá
Autoimmunity Reviews, 2014
Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-TNF therapy
Clinical and Experimental Rheumatology, 2014
Condyloma acuminatum in childhood-systemic lupus erythematosus patients
Acta Reumatologica Portuguesa, 2014
Pulmonary cryptococcosis in childhood systemic lupus erythematosus and Sjögren syndrome overlap: A rare opportunistic infection
VLS Marques, RC Gomes, GR Viola, MM Maia, GS Durigon, NE Aikawa, C Artur Silva
Lupus, 2013
Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients
NE Aikawa, G Trudes, LMA Campos, RMR Pereira, JCB Moraes, AC Ribeiro, J Miraglia, M do Carmo S Timenetsky, E Bonfa, CA Silva
Lupus, 2013
Vaccinations in juvenile chronic inflammatory diseases: An update
Clovis A. Silva, Nadia E. Aikawa, Eloisa Bonfa
Nature Reviews Rheumatology, 2013
High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus
Lucia M. A. Campos, Clovis A. Silva, Nadia E. Aikawa, Adriana A. Jesus, Julio C. B. Moraes, Joao Miraglia, Maria A. Ishida, Cleonice Bueno, Rosa M. R. Pereira, Eloisa Bonfa
Arthritis Care and Research, 2013
Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: Effect of disease and therapy
Renata Miossi, Ricardo Fuller, Júlio C.B. Moraes, Ana Cristina M. Ribeiro, Carla G.S. Saad, Nadia E. Aikawa, João L Miraglia, Maria A Ishida, Eloisa Bonfá, M Teresa C. Caleiro
Clinics, 2013
Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis
NE Aikawa, LMA Campos, C Goldenstein-Schainberg, CGS Saad, AC Ribeiro, C Bueno, AR Precioso, MdoC Timenetsky, CAA Silva, E Bonfá
Scandinavian Journal of Rheumatology, 2013
Mesenteric vasculitis in a juvenile systemic lupus erythematosus patient
Adão F. Albuquerque-Netto, Erica G. Cavalcante, Adriana M.E. Sallum, Nádia E. Aikawa, Uenis Tannuri, Clovis Artur Almeida da Silva
Revista Brasileira De Reumatologia, 2013
Profile of paediatric rheumatology specialists and services in the state of são paulo
Maria Teresa Terreri, Lúcia M.A. Campos, Eunice M. Okuda, Clovis A. Silva, Silvana B. Sacchetti, Roberto Marini, Virginia P. Ferriani, Maria Heloiza Ventura, Taciana Fernandes, Juliana O. Sato, Elizabeth C. Fernandes, Claudio Len, Cássia Barbosa, Ana Paola Lotito, Maria Carolina dos Santos, Nádia E. Aikawa, Mércia Facó, Daniela Piotto, Vanessa Bugni, Kátia T. Kozu, Paulo R. Romanelli, Adriana M.E. Sallum, Marília Febronio, Melissa Fraga, Cláudia S. Magalhães
Revista Brasileira De Reumatologia, 2013
Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease
Samuel Katsuyuki Shinjo, Júlio César Bertacini de Moraes, Maurício Levy-Neto, Nádia Emi Aikawa, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schahin Saad, Alexander Precioso, Clovis Artur Silva, Eloisa Bonfá
Vaccine, 2012
Tnf blockers show distinct patterns of immune response to the pandemic influenza a h1n1 vaccine in inflammatory arthritis patients
I. L. A. Franca, A. C. M. Ribeiro, N. E. Aikawa, C. G. S. Saad, J. C. B. Moraes, C. Goldstein-Schainberg, I. M. M. Laurindo, A. R. Precioso, M. A. Ishida, A. M. C. Sartori, C. A. Silva, E. Bonfa
Rheumatology United Kingdom, 2012
Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy
Clinical and Experimental Rheumatology, 2012
Invasive aspergillosis: A severe infection in juvenile systemic lupus erythematosus patients
MF Silva, AS Ribeiro, FJ Fiorot, NE Aikawa, AP Lotito, LM Campos, T Mauad, CA Silva
Lupus, 2012
Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
Clinical and Experimental Rheumatology, 2012
Influenza A H1N1/2009 vaccine in juvenile dermatomyositis: Reduced immunogenicity in patients under immunosuppressive therapy
Clinical and Experimental Rheumatology, 2012
Influenza A/H1N1 vaccination of patients with SLE: Can antimalarial drugs restore diminished response under immunosuppressive therapy?
E. F. Borba, C. G. S. Saad, S. G. Pasoto, A. L. G. Calich, N. E. Aikawa, A. C. M. Ribeiro, J. C. B. Moraes, E. P. Leon, L. P. Costa, L. K. N. Guedes, C. A. A. Silva, C. R. Goncalves, R. Fuller, S. A. Oliveira, M. A. Ishida, A. R. Precioso, E. Bonfa
Rheumatology United Kingdom, 2012
Anti-TNF therapy for polymyalgia rheumatica: Report of 99 cases and review of the literature
Nádia Emi Aikawa, Rosa Maria Rodrigues Pereira, Laís Lage, Eloisa Bonfá, Jozélio Freire Carvalho
Clinical Rheumatology, 2012
Lupus erythematosus panniculitis in children and adolescents
Acta Reumatologica Portuguesa, 2012
Kawasaki disease and juvenile systemic lupus erythematosus
JC Diniz, RT Almeida, NE Aikawa, AME Sallum, PT Sakane, CA Silva
Lupus, 2012
Glucocorticoid: Major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease
NADIA E. AIKAWA, LUCIA M.A. CAMPOS, CLOVIS A. SILVA, JOZELIO F. CARVALHO, CARLA G.S. SAAD, GUILHERME TRUDES, ALBERTO DUARTE, JOAO L. MIRAGLIA, MARIA do CARMO S. TIMENETSKY, VILMA S.T. VIANA, IVAN L.A. FRANÇA, ELOISA BONFA, ROSA M.R. PEREIRA
Journal of Rheumatology, 2012
Association of systemic - onset juvenile idiopathic arthritis and celiac disease - A case repor
Acta Reumatologica Portuguesa, 2011
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: Implications for clinical practice
Ana C M Ribeiro, Lissiane K N Guedes, Julio C B Moraes, Carla G S Saad, Nadia E Aikawa, Ana Luisa Calich, Ivan L A França, Jozelio F Carvalho, Percival D Sampaio-Barros, Celio R Goncalves, Eduardo F Borba, Maria do Carmo S Timenetsky, Alexander R Precioso, Alberto Duarte, Eloisa Bonfa, Ieda M M Laurindo
Annals of the Rheumatic Diseases, 2011
Immunogenicity and reactogenicity of 2009 influenza a (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients
João L. Miraglia, Edson Abdala, Paulo M. Hoff, André M. Luiz, Danise S. Oliveira, Carla G. S. Saad, Ieda M. M. Laurindo, Ana T. R. Viso, Angela Tayra, Lígia C. Pierrotti, Luiz S. Azevedo, Lúcia Maria A. Campos, Nádia E. Aikawa, Maria do Carmo S. T. Timenetsky, Expedito Luna, Maria Regina A. Cardoso, José da S. Guedes, Isaias Raw, Jorge Kalil, Alexander R. Precioso
Plos One, 2011
Stevens-Johnson syndrome in a juvenile systemic lupus erythematosus patient
EG Cavalcante, VR Guissa, AA Jesus, LMA Campos, AM Sallum, NE Aikawa, CA Silva
Lupus, 2011
Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset
Mirian S Tamashiro, Nádia Emi Aikawa, Lucia Maria A Campos, Lílian Maria Cristofani, Vicente Odone-Filho, Clovis A Silva
Clinics, 2011
Penile and scrotum swelling in juvenile dermatomyositis
Acta Reumatologica Portuguesa, 2011
Intestinal microsporidiosis: A hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
Nadia Emi Aikawa, Aline de Oliveira Twardowsky, Jozélio Freire de Carvalho, Clovis A Silva, Ivan Leonardo Avelino França e Silva, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schain Saad, Julio César Bertacini Moraes, Roberto Acayaba de Toledo, Eloísa Bonfá
Clinics, 2011
Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease
Nádia Emi Aikawa, Carla Gonçalves, Clovis Artur Almeida Silva, Célio Gonçalves, Eloísa Bonfá, Jozélio Freire de Carvalho
Rheumatology International, 2011
Is anti-TNF switching in refractory Still's disease safe and effective?
Nadia Emi Aikawa, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schain Saad, Rosa Maria Rodrigues Pereira, Mauricio Levy, Clovis A. Silva, Eloísa Bonfá, Jozélio Freire de Carvalho
Clinical Rheumatology, 2011
Chronic autoimmune urticaria as the first manifestation of juvenile systemic lupus erythematosus
MS Spadoni, CMA Jacob, NE Aikawa, AA Jesus, ÂB Fomin, CA da Silva
Lupus, 2011
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
Carla G S Saad, Eduardo F Borba, Nadia E Aikawa, Clovis A Silva, Rosa M R Pereira, Ana Luisa Calich, Julio C B Moraes, Ana C M Ribeiro, Vilma S T Viana, Sandra G Pasoto, Jozelio F Carvalho, Ivan L A França, Lissiane K N Guedes, Samuel K Shinjo, Percival D Sampaio-Barros, Maria T Caleiro, Celio R Goncalves, Ricardo Fuller, Mauricio Levy-Neto, Maria do Carmo S Timenetsky, Alexander R Precioso, Eloisa Bonfa
Annals of the Rheumatic Diseases, 2011
Irreversible blindness in juvenile systemic lupus erythematosus
RT Almeida, NE Aikawa, AME Sallum, AA Jesus, LCF Sa, CA Silva
Lupus, 2011
Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients
EGN Cavalcante, NE Aikawa, RG Lozano, APN Lotito, AA Jesus, CA Silva
Lupus, 2011
Infliximab induces increase in triglyceride levels in psoriatic arthritis patients
Karla R. Castro, Nádia E. Aikawa, Carla Gonçalves Saad, Júlio C. B. Moraes, Ana C. Medeiros, Licia Maria H. Mota, Clovis A. A. Silva, Eloísa Bonfá, Jozélio F. Carvalho
Clinical and Developmental Immunology, 2011
Menstrual and hormonal alterations in juvenile dermatomyositis
Clinical and Experimental Rheumatology, 2010
Schnitzler's syndrome improvement after anti-TNF-alpha therapy
Nádia Emi Aikawa, Clovis Artur A. Silva, Eloísa Bonfá, Jozélio Freire de Carvalho
Joint Bone Spine, 2010
Vaccination practice in children with rheumatic disease
Revista Brasileira De Reumatologia, 2010
Immediate complications of 3,555 injections of anti-TNFα
Revista Brasileira De Reumatologia, 2010
Treatment with biologic agents in child and adolescent
Ricardo Maisse Suehiro, Nádia Emi Aikawa, Jozélio Freire de Carvalho, Clovis Artur A. da Silva
Revista Paulista De Pediatria, 2010
Immunogenicity of anti-TNF-α agents in autoimmune diseases
Nádia Emi Aikawa, Jozélio Freire de Carvalho, Clovis Artur Almeida Silva, Eloísa Bonfá
Clinical Reviews in Allergy and Immunology, 2010
Improvement of Schnitzler syndrome under anti-TNFα treatment
Nádia Emi Aikawa, Clovis Artur A. Silva, Eloísa Bonfá, Jozélio Freire de Carvalho
Revue Du Rhumatisme Edition Francaise, 2010
Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis
Israel Medical Association Journal, 2009
Peripheral polineuropathy in patients with juvenile systemic lupus erythematosus
Roberta Tavares Almeida, Lúcia Maria de Arruda Campos, Nádia Emi Aikawa, Kátia Tomie Kozue, José Albino da Paz, Maria Joaquina Marques-Dias, Clovis Artur Almeida Silva
Revista Brasileira De Reumatologia, 2009
Immunization consensus for children and adolescents with rheumatic diseases
Clovis Artur A Silva, Maria Teresa R. A Terreri, Cássia Maria P.L Barbosa, Maria Odete E Hilário, Gecilmara C. S Pillegi, Virginia P.L Ferriani, Nadia E Aikawa, Jozélio F Carvalho, Adriana A Jesus, Adriana M. E Sallum, Ana Paola N Lotito, Bernadete L Liphaus, Claudia S Magalhães, Cláudio A Len, Eunice M Okuda, Lucia Maria M Campos, Luciana M Carvalho, Marcos Vinícius Ronchezel, Maria Carolina dos Santos, Paulo Roberto S Romanelli, Roberto Marini, Rosa Maria R Pereira, Silvana B Sacchetti, Simone Lotufo, Sônia Maria S Hirschheimer, Tereza Cristina M.V Robazzi, Ana Paula Vecchi, Ana Júlia P Moraes, Erica N Naka, Blanca Bica, Sheila K.F Oliveira, Wanda A Bastos
Revista Brasileira De Reumatologia, 2009
Risk factors associated with calcinosis of juvenile dermatomyositis
Adriana M. E. Sallum, Francine C. M. M. Pivato, Ulysses Doria-Filho, Nádia E. Aikawa, Bernadete L. Liphaus, Suely K. N. Marie, Clóvis A. A. Silva
Jornal De Pediatria, 2008
Topical tacrolimus in refractory skin lesions of juvenile dermatomiosytis
Carlos Nobre Rabelo Júnior, Nádia Emi Aikawa, Kátia Tomie Kozu, Adriana Maluf Elias Sallum, Lúcia Maria Arruda Campos, Clovis Artur Almeida da Silva
Revista Brasileira De Reumatologia, 2007
Hypertension in employees of a University General Hospital.
Decio Mion Jr., Angela M. G. Pierin, Alberto P. Bambirra, Jorge H. Assunção, Juliana M. Monteiro, Roberta Y. Chinen, Roger B. Coser, Vânia N. Aikawa, Fernanda M. Cação, Mariana Hausen, Marcelo F. Vilibor, Nádia E. Aikawa, Sérgio N. Konno, Roger B. Coser
Revista do Hospital Das Clinicas, 2004

Nadia Emi Aikawa

EDUCATION

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS